Department of Neurosciences, University of Palermo, Palermo, Italy
Brief Report
Preliminary Findings: Impact of a Single OnabotulinumtoxinA Therapy Session on Sleep Quality and Psychological Measures in Chronic Migraine Patients
Author(s): Paolo Lupica*
This study investigates the immediate effects of a single session of OnabotulinumtoxinA therapy on sleep quality and psychological measures in patients suffering from chronic migraine. Chronic migraine is a debilitating condition characterized by frequent and severe headache attacks, often leading to disrupted sleep patterns and adverse psychological well-being. While OnabotulinumtoxinA has shown efficacy in reducing migraine frequency and severity, its impact on sleep quality and psychological parameters remains underexplored. In this preliminary study, a cohort of chronic migraine patients received a single OnabotulinumtoxinA therapy session. Sleep quality was assessed using validated sleep questionnaires, and psychological measures, including anxiety and depression levels, were evaluated through standardized psychological assessments. Baseline measures were compared with post-treat.. Read More»
DOI:
10.37421/2472-0895.2023.9.210
Epilepsy Journal received 41 citations as per Google Scholar report